Current Edition

Regional News

US secures more Lilly COVID-19 antibodies for $275M, but with pandemic funding uncertain this may be a swan song

Developing an antibody treatment that is effective against the omicron variant of COVID-19 has paying off for Eli Lilly. But the company may soon lose …

Continue Reading →
Regional News

Gilead, Sanofi, GSK and more to pay for employees’ abortion-related travel costs after Roe ruling

After the Supreme Court overturned the landmark Roe v. Wade ruling, companies across industries are stepping in to support employees who need to cross state …

Continue Reading →
Regional News

With Congress weighing insulin cost cap, Sanofi slashes price for uninsured in US

With Congress weighing a cap on out-of-pocket costs for insulin for certain individuals, Sanofi has beaten the government to the punch. The Paris-based company says it will …

Continue Reading →
Regional News

Johnson & Johnson refreshes ‘Positively Fearless’ HIV campaign with a new digital presence and LGBTQ+ ambassador

Johnson & Johnson is boosting its “Positively Fearless” HIV campaign as it looks to break the old stigma attached to the disease whilst boosting its …

Continue Reading →
Regional News

Fujifilm plots $1.6B expansion at CDMO sites in Denmark and Texas, adding 450 jobs

Fujifilm isn’t slowing down on its expansion roll. Just a few months after it bought Shenandoah Biotechnology for an undisclosed sum, the Japanese conglomerate has unveiled …

Continue Reading →
Regional News

‘Leaner and simpler’: Novartis details plans to cut 8,000 jobs worldwide

For months, Novartis has hinted at layoffs coming for some of its global staff. Now, the news has come down from HQ. Novartis is laying …

Continue Reading →
Regional News

Eli Lilly finds stigma is one of the worst parts of migraine as it aims to help break the taboo

It turns out that even more than the blinding pain, the nausea, the photosensitivity or crushing fatigue, the worst part of migraine is often the …

Continue Reading →
Regional News

Game on, Pfizer: Merck’s Vaxneuvance boosts pneumococcal vaccine fight with coveted pediatric nod

This spring, when the FDA pushed its target date for pediatric approval of Merck’s pneumococcal vaccine Vaxneuvance back by 90 days, it was a blow …

Continue Reading →
Regional News

Florida man arrested in scheme to sell $230M in adulterated HIV meds to unsuspecting patients

As authorities continue to probe irregularities in the HIV drug supply chain, a Florida man has been arrested for his alleged role in a nationwide scheme to …

Continue Reading →
Regional News

BMS, Pfizer and Merck face steep patent cliffs but all have the financial flexibility for M&A: Moody’s

Bristol Myers Squibb, Pfizer and Merck will face extreme patent cliff exposure later in this decade. But those companies also have the financial flexibility to …

Continue Reading →